These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
229 related articles for article (PubMed ID: 11245059)
21. INFECTIOUSNESS OF SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS WITH CYTOMEGALOVIRUS AND EPSTEIN-BARR VIRUS. Guta S; Abrahamovych O; Abrahamovych U; Tsyhanyk L; Farmaha M Georgian Med News; 2023 May; (338):121-125. PubMed ID: 37419485 [TBL] [Abstract][Full Text] [Related]
22. Complementary serum test of antibodies to Epstein-Barr virus nuclear antigen-1 and early antigen: a possible alternative for primary screening of nasopharyngeal carcinoma. Chang KP; Hsu CL; Chang YL; Tsang NM; Chen CK; Lee TJ; Tsao KC; Huang CG; Chang YS; Yu JS; Hao SP Oral Oncol; 2008 Aug; 44(8):784-92. PubMed ID: 18206420 [TBL] [Abstract][Full Text] [Related]
23. Epstein-Barr virus in autoimmune diseases. Toussirot E; Roudier J Best Pract Res Clin Rheumatol; 2008 Oct; 22(5):883-96. PubMed ID: 19028369 [TBL] [Abstract][Full Text] [Related]
24. Association of clinical and serological parameters of systemic lupus erythematosus patients with Epstein-Barr virus antibody profile. Chougule D; Nadkar M; Rajadhyaksha A; Pandit-Shende P; Surve P; Dawkar N; Khadilkar P; Patwardhan M; Kaveri S; Ghosh K; Pradhan V J Med Virol; 2018 Mar; 90(3):559-563. PubMed ID: 28734074 [TBL] [Abstract][Full Text] [Related]
25. Serologic response to Epstein-Barr virus antigens in patients with systemic lupus erythematosus: a controlled study. Esen BA; Yılmaz G; Uzun S; Ozdamar M; Aksözek A; Kamalı S; Türkoğlu S; Gül A; Ocal L; Aral O; Inanç M Rheumatol Int; 2012 Jan; 32(1):79-83. PubMed ID: 20661740 [TBL] [Abstract][Full Text] [Related]
26. Association of Epstein-Barr virus serological reactivation with transitioning to systemic lupus erythematosus in at-risk individuals. Jog NR; Young KA; Munroe ME; Harmon MT; Guthridge JM; Kelly JA; Kamen DL; Gilkeson GS; Weisman MH; Karp DR; Gaffney PM; Harley JB; Wallace DJ; Norris JM; James JA Ann Rheum Dis; 2019 Sep; 78(9):1235-1241. PubMed ID: 31217170 [TBL] [Abstract][Full Text] [Related]
27. Aberrant Epstein-Barr virus persistence in HIV carriers is characterized by anti-Epstein-Barr virus IgA and high cellular viral loads with restricted transcription. Stevens SJ; Smits PH; Verkuijlen SA; Rockx DA; van Gorp EC; Mulder JW; Middeldorp JM AIDS; 2007 Oct; 21(16):2141-9. PubMed ID: 18090040 [TBL] [Abstract][Full Text] [Related]
28. Immune responses to Epstein-Barr virus lytic proteins in patients with nasopharyngeal carcinoma. Liu MY; Huang YT; Sheen TS; Chen JY; Tsai CH J Med Virol; 2004 Aug; 73(4):574-82. PubMed ID: 15221902 [TBL] [Abstract][Full Text] [Related]
30. Phenotypic and functional analysis of EBV-specific memory CD8 cells in SLE. Berner BR; Tary-Lehmann M; Yonkers NL; Askari AD; Lehmann PV; Anthony DD Cell Immunol; 2005 May; 235(1):29-38. PubMed ID: 16181618 [TBL] [Abstract][Full Text] [Related]
31. IgM serum antibodies to Epstein-Barr virus are uniquely present in a subset of patients with the chronic fatigue syndrome. Lerner AM; Beqaj SH; Deeter RG; Fitzgerald JT In Vivo; 2004; 18(2):101-6. PubMed ID: 15113035 [TBL] [Abstract][Full Text] [Related]
32. Correlation between cytomegalovirus infection and Raynaud's phenomenon in lupus nephritis. Stratta P; Canavese C; Ciccone G; Santi S; Quaglia M; Ghisetti V; Marchiaro G; Barbui A; Fop F; Cavallo R; Piccoli G Nephron; 1999 Jun; 82(2):145-54. PubMed ID: 10364707 [TBL] [Abstract][Full Text] [Related]
33. Analysis of Epstein-Barr viral DNA load, EBV-LMP2 specific cytotoxic T-lymphocytes and levels of CD4+CD25+ T cells in patients with nasopharyngeal carcinomas positive for IgA antibody to EBV viral capsid antigen. Mo WN; Tang AZ; Zhou L; Huang GW; Wang Z; Zeng Y Chin Med J (Engl); 2009 May; 122(10):1173-8. PubMed ID: 19493466 [TBL] [Abstract][Full Text] [Related]
34. Epstein-Barr virus induces normal B cell responses but defective suppressor T cell responses in patients with systemic lupus erythematosus. Tsokos GC; Magrath IT; Balow JE J Immunol; 1983 Oct; 131(4):1797-801. PubMed ID: 6311898 [TBL] [Abstract][Full Text] [Related]
35. Enhancement of Epstein-Barr virus antibody production in systemic lupus erythematosus patients. Stancek D; Robenský J Acta Virol; 1979 Mar; 23(2):168-9. PubMed ID: 39442 [TBL] [Abstract][Full Text] [Related]
36. Sensitivity and specificity of Epstein-Barr virus IGA titer in the diagnosis of nasopharyngeal carcinoma: a three-year institutional review. Tsang RK; Vlantis AC; Ho RW; Tam JS; To KF; van Hasselt CA Head Neck; 2004 Jul; 26(7):598-602. PubMed ID: 15229902 [TBL] [Abstract][Full Text] [Related]
37. Antibody patterns against cytomegalovirus and Epstein-Barr virus in human atherosclerosis. Musiani M; Zerbini ML; Muscari A; Puddu GM; Gentilomi G; Gibellini D; Gallinella G; Puddu P; La Placa M Microbiologica; 1990 Jan; 13(1):35-41. PubMed ID: 2155375 [TBL] [Abstract][Full Text] [Related]
38. Epstein-Barr virus antibodies in patients with laryngeal and hypopharyngeal cancer. Morshed K; Polz-Dacewicz M; Szymański M; Rajtar B; Ziaja-Sołtys M; Gołabek W Ann Univ Mariae Curie Sklodowska Med; 2003; 58(2):227-31. PubMed ID: 15323196 [TBL] [Abstract][Full Text] [Related]
39. Epstein-Barr virus and human immunodeficiency virus serological responses and viral burdens in HIV-infected patients treated with HAART. O'Sullivan CE; Peng R; Cole KS; Montelaro RC; Sturgeon T; Jenson HB; Ling PD J Med Virol; 2002 Jul; 67(3):320-6. PubMed ID: 12116021 [TBL] [Abstract][Full Text] [Related]
40. Detection of Epstein-Barr virus and cytomegalovirus genome in white blood cells from patients with juvenile rheumatoid arthritis and childhood systemic lupus erythematosus. Tsai YT; Chiang BL; Kao YF; Hsieh KH Int Arch Allergy Immunol; 1995 Mar; 106(3):235-40. PubMed ID: 7888786 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]